ATE479667T1 - Als kinaseinhibitoren geeignete verbindungen auf thiazolylbasis - Google Patents
Als kinaseinhibitoren geeignete verbindungen auf thiazolylbasisInfo
- Publication number
- ATE479667T1 ATE479667T1 AT04709122T AT04709122T ATE479667T1 AT E479667 T1 ATE479667 T1 AT E479667T1 AT 04709122 T AT04709122 T AT 04709122T AT 04709122 T AT04709122 T AT 04709122T AT E479667 T1 ATE479667 T1 AT E479667T1
- Authority
- AT
- Austria
- Prior art keywords
- sup
- thiazolyl
- based compounds
- kinase inhibitors
- kinase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US44541003P | 2003-02-06 | 2003-02-06 | |
| PCT/US2004/003879 WO2004071440A2 (en) | 2003-02-06 | 2004-02-06 | Thiazolyl-based compounds useful as kinase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE479667T1 true ATE479667T1 (de) | 2010-09-15 |
Family
ID=32869361
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04709122T ATE479667T1 (de) | 2003-02-06 | 2004-02-06 | Als kinaseinhibitoren geeignete verbindungen auf thiazolylbasis |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US7169771B2 (de) |
| EP (1) | EP1594854B1 (de) |
| AT (1) | ATE479667T1 (de) |
| DE (1) | DE602004028907D1 (de) |
| ES (1) | ES2349532T3 (de) |
| WO (1) | WO2004071440A2 (de) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004072068A1 (en) * | 2003-02-10 | 2004-08-26 | Amgen Inc. | Vanilloid receptor ligands and their use in treatments |
| WO2004098528A2 (en) | 2003-05-01 | 2004-11-18 | Bristol-Myers Squibb Company | Pyrazole-amine compounds useful as kinase inhibitors |
| GB0329572D0 (en) | 2003-12-20 | 2004-01-28 | Astrazeneca Ab | Amide derivatives |
| US7491725B2 (en) | 2004-02-06 | 2009-02-17 | Bristol-Myers Squibb Company | Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors |
| US20050215795A1 (en) * | 2004-02-06 | 2005-09-29 | Bang-Chi Chen | Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors |
| TWI338004B (en) * | 2004-02-06 | 2011-03-01 | Bristol Myers Squibb Co | Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors |
| US7652146B2 (en) | 2004-02-06 | 2010-01-26 | Bristol-Myers Squibb Company | Process for preparing 2-aminothiazole-5-carboxamides useful as kinase inhibitors |
| TW200628156A (en) * | 2004-11-04 | 2006-08-16 | Bristol Myers Squibb Co | Combination of a SRC kinase inhibitor and a BCR-ABL inhibitor for the treatment of proliferative diseases |
| CA2588517A1 (en) * | 2004-12-01 | 2006-06-08 | Devgen N.V. | 5-carboxamido substituted thiazole derivatives that interact with ion channels, in particular with ion channels from the kv family |
| EP1841431A4 (de) * | 2005-01-26 | 2009-12-09 | Irm Llc | Verbindungen und zusammensetzungen als proteinkinase-hemmer |
| US20060178388A1 (en) * | 2005-02-04 | 2006-08-10 | Wrobleski Stephen T | Phenyl-substituted pyrimidine compounds useful as kinase inhibitors |
| KR101142283B1 (ko) * | 2005-03-11 | 2012-05-07 | 스미또모 가가꾸 가부시끼가이샤 | 2-아미노티아졸 카르복사미드 유도체의 신규한 제조방법 |
| ZA200800608B (en) | 2005-06-21 | 2009-06-24 | Mitsui Chemicals Inc | Amide derivative and insecticide containing the same |
| WO2007138110A2 (en) * | 2006-06-01 | 2007-12-06 | Devgen N.V. | Compounds that interact with ion channels, in particular with ion channels from the kv family |
| AU2007301607A1 (en) * | 2006-09-25 | 2008-04-03 | Mutabilis Sa | Substituted heterocyclylcarbonylamino-acetic-acid-derivatives as inhibitors of bacterial heptose synthesis, methods for their preparation and biological applications of said inhibitors |
| EP2468717B1 (de) | 2006-10-27 | 2013-11-20 | Bristol-Myers Squibb Company | Heterocyclische Amidverbindungen als Kinasehemmer |
| US8148400B2 (en) * | 2006-12-20 | 2012-04-03 | Bristol-Myers Squibb Company | Thiazolyl compounds useful as kinase inhibitors |
| US7737149B2 (en) | 2006-12-21 | 2010-06-15 | Astrazeneca Ab | N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(3,5-dimethylpiperazin-1-yl)benzamide and salts thereof |
| RU2461551C2 (ru) | 2007-10-24 | 2012-09-20 | Астеллас Фарма Инк. | Азолкарбоксамидное соединение или его фармацевтически приемлемая соль |
| WO2009132310A1 (en) * | 2008-04-25 | 2009-10-29 | Wisconsin Alumni Research Foundation | Inhibitors of udp-galactopyranose mutase thwart mycobacterial growth |
| US8765747B2 (en) | 2009-06-12 | 2014-07-01 | Dana-Farber Cancer Institute, Inc. | Fused 2-aminothiazole compounds |
| EP2519517B1 (de) | 2009-12-29 | 2015-03-25 | Dana-Farber Cancer Institute, Inc. | Typ-ii-raf-kinase-hemmer |
| US9290485B2 (en) | 2010-08-04 | 2016-03-22 | Novartis Ag | N-((6-amino-pyridin-3-yl)methyl)-heteroaryl-carboxamides |
| EP2822935B1 (de) | 2011-11-17 | 2019-05-15 | Dana-Farber Cancer Institute, Inc. | Inhibitoren der c-jun-n-terminal-kinase (jnk) |
| RU2495430C1 (ru) * | 2012-03-29 | 2013-10-10 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Астраханская государственная академия" Министерства здравоохранения и социального развития Российской Федерации (ГБОУ ВПО АГМА Минздравсоцразвития России) | Способ оценки эффективности терапии хронического миелолейкоза |
| RU2495427C1 (ru) * | 2012-07-04 | 2013-10-10 | Федеральное бюджетное учреждение науки "Уфимский научно-исследовательский институт медицины труда и экологии человека" | Способ прогнозирования ответа на химиотерапию при хроническом лимфолейкозе |
| EP2909194A1 (de) | 2012-10-18 | 2015-08-26 | Dana-Farber Cancer Institute, Inc. | Hemmer der cyclinabhängigen kinase 7 (cdk7) |
| WO2014063061A1 (en) | 2012-10-19 | 2014-04-24 | Dana-Farber Cancer Institute, Inc. | Hydrophobically tagged small molecules as inducers of protein degradation |
| US10000483B2 (en) | 2012-10-19 | 2018-06-19 | Dana-Farber Cancer Institute, Inc. | Bone marrow on X chromosome kinase (BMX) inhibitors and uses thereof |
| US20140179712A1 (en) | 2012-12-21 | 2014-06-26 | Astrazeneca Ab | Pharmaceutical formulation of n-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2h-pyrazol-3-yl]-4-[(3r,5s)-3,5-dimethylpiperazin-1-yl]benzamide |
| US20160264551A1 (en) | 2013-10-18 | 2016-09-15 | Syros Pharmaceuticals, Inc. | Heteroaromatic compounds useful for the treatment of prolferative diseases |
| EP3057956B1 (de) | 2013-10-18 | 2021-05-05 | Dana-Farber Cancer Institute, Inc. | Polycyclische inhibitoren der cyclin-dependent-kinase 7 (cdk7) |
| WO2015164604A1 (en) | 2014-04-23 | 2015-10-29 | Dana-Farber Cancer Institute, Inc. | Hydrophobically tagged janus kinase inhibitors and uses thereof |
| WO2015164614A1 (en) | 2014-04-23 | 2015-10-29 | Dana-Farber Cancer Institute, Inc. | Janus kinase inhibitors and uses thereof |
| WO2016105528A2 (en) | 2014-12-23 | 2016-06-30 | Dana-Farber Cancer Institute, Inc. | Inhibitors of cyclin-dependent kinase 7 (cdk7) |
| US10550121B2 (en) | 2015-03-27 | 2020-02-04 | Dana-Farber Cancer Institute, Inc. | Inhibitors of cyclin-dependent kinases |
| WO2016201370A1 (en) | 2015-06-12 | 2016-12-15 | Dana-Farber Cancer Institute, Inc. | Combination therapy of transcription inhibitors and kinase inhibitors |
| EP4019515A1 (de) | 2015-09-09 | 2022-06-29 | Dana-Farber Cancer Institute, Inc. | Hemmer von cyclinabhängigen kinasen |
| US20190060286A1 (en) | 2016-02-29 | 2019-02-28 | University Of Florida Research Foundation, Incorpo | Chemotherapeutic Methods |
| US10080757B2 (en) | 2016-03-11 | 2018-09-25 | Wisconsin Alumni Research Foundation | Inhibitors of UDP-galactopyranose mutase |
| PE20211496A1 (es) * | 2018-05-09 | 2021-08-11 | Lg Chemical Ltd | Nuevo compuesto que presenta actividad inhibidora de enteropeptidasa |
| TWI815137B (zh) | 2018-06-15 | 2023-09-11 | 漢達生技醫藥股份有限公司 | 尼洛替尼十二烷基硫酸鹽之結晶 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4200750A (en) | 1977-01-07 | 1980-04-29 | Westwood Pharmaceuticals Inc. | 4-Substituted imidazo [1,2-a]quinoxalines |
| US5739135A (en) | 1993-09-03 | 1998-04-14 | Bristol-Myers Squibb Company | Inhibitors of microsomal triglyceride transfer protein and method |
| US5760246A (en) | 1996-12-17 | 1998-06-02 | Biller; Scott A. | Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method |
| US6605599B1 (en) | 1997-07-08 | 2003-08-12 | Bristol-Myers Squibb Company | Epothilone derivatives |
| US6262096B1 (en) | 1997-11-12 | 2001-07-17 | Bristol-Myers Squibb Company | Aminothiazole inhibitors of cyclin dependent kinases |
| SI0928790T1 (en) * | 1998-01-02 | 2003-06-30 | F. Hoffmann-La Roche Ag | Thiazole derivatives |
| BR9915744A (pt) | 1998-12-04 | 2001-08-21 | Bristol Myers Squibb Co | Derivados 4-arilquinolin-2-ona 3-substituìdos como moduladores do canal de potássio |
| AU771089B2 (en) | 1999-02-22 | 2004-03-11 | Bristol-Myers Squibb Company | C-21 modified epothilones |
| US6548529B1 (en) | 1999-04-05 | 2003-04-15 | Bristol-Myers Squibb Company | Heterocyclic containing biphenyl aP2 inhibitors and method |
| US7125875B2 (en) * | 1999-04-15 | 2006-10-24 | Bristol-Myers Squibb Company | Cyclic protein tyrosine kinase inhibitors |
| BR0009721A (pt) * | 1999-04-15 | 2002-02-13 | Bristol Myers Squibb Co | Inibidores de tirosina quinase de proteìna cìclica |
| EP1205478A4 (de) | 1999-08-06 | 2004-06-30 | Takeda Chemical Industries Ltd | INHIBITOREN DER p38MAP-KINASE |
| SE9904177D0 (sv) | 1999-11-18 | 1999-11-18 | Astra Ab | Novel compounds |
| MY125533A (en) | 1999-12-06 | 2006-08-30 | Bristol Myers Squibb Co | Heterocyclic dihydropyrimidine compounds |
| US6906067B2 (en) * | 1999-12-28 | 2005-06-14 | Bristol-Myers Squibb Company | N-heterocyclic inhibitors of TNF-α expression |
| US20020065270A1 (en) * | 1999-12-28 | 2002-05-30 | Moriarty Kevin Joseph | N-heterocyclic inhibitors of TNF-alpha expression |
| MY138097A (en) * | 2000-03-22 | 2009-04-30 | Du Pont | Insecticidal anthranilamides |
| AU2001244618A1 (en) * | 2000-03-30 | 2001-10-15 | Takeda Chemical Industries Ltd. | Substituted 1,3-thiazole compounds, their production and use |
| US20020137755A1 (en) | 2000-12-04 | 2002-09-26 | Bilodeau Mark T. | Tyrosine kinase inhibitors |
| ATE339418T1 (de) | 2001-06-01 | 2006-10-15 | Vertex Pharma | Thiazolverbindungen, die sich als inhibitoren von proteinkinasen eignen |
| HN2002000156A (es) * | 2001-07-06 | 2003-11-27 | Inc Agouron Pharmaceuticals | Derivados de benzamida tiazol y composiciones farmaceuticas para inhibir la proliferacion de celulas y metodos para su utilización. |
| EP1429764A1 (de) * | 2001-08-31 | 2004-06-23 | Bristol-Myers Squibb Company | Zusammensetzungen und verfahren für die krebsbehandlung |
| WO2003050261A2 (en) * | 2001-12-10 | 2003-06-19 | Bristol-Myers Squibb Company | (1-phenyl-2-heteroaryl)ethyl-guanidine compounds as inhibitors of mitochondrial f1f0 atp hydrolase |
-
2004
- 2004-02-06 US US10/773,790 patent/US7169771B2/en active Active
- 2004-02-06 AT AT04709122T patent/ATE479667T1/de not_active IP Right Cessation
- 2004-02-06 WO PCT/US2004/003879 patent/WO2004071440A2/en active Application Filing
- 2004-02-06 ES ES04709122T patent/ES2349532T3/es not_active Expired - Lifetime
- 2004-02-06 DE DE602004028907T patent/DE602004028907D1/de not_active Expired - Lifetime
- 2004-02-06 EP EP04709122A patent/EP1594854B1/de not_active Expired - Lifetime
-
2006
- 2006-12-04 US US11/633,337 patent/US7323482B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1594854A4 (de) | 2007-07-18 |
| WO2004071440A2 (en) | 2004-08-26 |
| US20070093537A1 (en) | 2007-04-26 |
| DE602004028907D1 (de) | 2010-10-14 |
| US7323482B2 (en) | 2008-01-29 |
| US20040220233A1 (en) | 2004-11-04 |
| ES2349532T3 (es) | 2011-01-04 |
| US7169771B2 (en) | 2007-01-30 |
| EP1594854B1 (de) | 2010-09-01 |
| WO2004071440A3 (en) | 2004-12-09 |
| EP1594854A2 (de) | 2005-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE479667T1 (de) | Als kinaseinhibitoren geeignete verbindungen auf thiazolylbasis | |
| ATE482200T1 (de) | Als kinaseinhibitoren geeignete arylsubstituierte pyrazolamidverbindungen | |
| EA200601830A1 (ru) | Ортозамещённые арильные или гетероарильные амидные соединения | |
| ATE338461T1 (de) | Pyrazolpyrimidinfungizide | |
| NO20062185L (no) | Hepatitt C virus-inhibitorer | |
| WO2007016392A3 (en) | Benzothiazole and azabenzothiazole compounds useful as kinase inhibitors | |
| DE60212867D1 (de) | Thiazolylsubstituierte aminopyrimidine als pflanzenschutzmittel | |
| NO20062267L (no) | Hepatitt C virus inhibitorer | |
| DK1070056T3 (da) | Phthalazinon-PDE III/IV-inhibitorer | |
| WO2005092858A3 (en) | Alpha aryl or heteroaryl methyl beta piperidino propanamide compounds as orl1-receptor antagonist | |
| NO20062339L (no) | Hepatitt C virus-inhibitoerer | |
| GEP20074148B (en) | Pyrrolo-triazine aniline compounds useful as kinase inhibitors | |
| MXPA05012837A (es) | Inhibidores de caspasa y usos de los mismos. | |
| DE602005025332D1 (de) | 4-ä2-(cycloalkylamino)pyrimidin-4-ylü-(phenyl)imidazolin-2-onderivate als inhibitoren der p38-map-kinase zur behandlung von entzündlichen krankheiten | |
| ATE543803T1 (de) | 3-ä2-(3-azylamino-2-oxo-2h-pyridin-1- yl)acetylaminoü-4-oxopentansäurederivate und deren verwendung als caspase-inhibitoren | |
| CO5680420A2 (es) | Compuestos de 6-amino-1h-indazol y 4-aminobenzenofurano como inhibidores de la fosfodiesterasa 4 | |
| ATE399168T1 (de) | Imidazopyridin-derivate und ihre verwendung als induzierbare no-synthase inhibitoren | |
| DE60314381D1 (de) | Benzylimidazolyl substituierte 2-chinolon und chinazolinon derivate zur verwendung als farnesyl transferase inhibitoren | |
| DE602004005881D1 (de) | Substituierte pyrazinonverbindungen zur behandlung von entzündungen | |
| DE602006010702D1 (de) | Homomorpholinoxazolidinone als antibakterielle mittel | |
| EA200300458A1 (ru) | Новые соединения аминотриазолона, способ их получения и фармацевтические композиции, содержащие их | |
| BR0308935A (pt) | Inibidor de fosfodiesterase iv contendo derivado de piridilacrilamida | |
| DE502004009016D1 (de) | Verwendung von chinaldin-und naphthalinderivaten als kristallisationsmodifikatoren | |
| ATE449760T1 (de) | Nichtpeptidinhibitoren von matrixmetalloproteinasen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |